BIOPHARMASPEC
Live / Registered — Registered — Section 71 accepted (as of 05 Jun 2025)
What this means for you
Registered since 01 Sept 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79154693
- Registration number
- 4801698
- Mark type
- Stylized text
- Filed
- 22 Apr 2014
- Published for opposition
- 16 Jun 2015
- Registered
- 01 Sept 2015
- Attorney of record
- Hara K. Jacobs
Goods and services
- Class 041 — Education and entertainment services: Educational, training and instructional services in the nature of courses, seminars, tutorials, conferences and workshops in the field of scientific research and analysis; providing education and training services, namely, training courses, seminars, tutorials, conferences and workshops on scientific analysis and analytical techniques; production of sound and video recordings in the field of scientific research and analysis for training purposes; publication of training manuals and educational, instructional and teaching materials; publication of scientific reports and texts; providing online electronic publications, namely, electronic books and journals in the field of scientific research and analysis; information, advisory and consultancy services relating to all of the aforesaid services
- Class 042 — Scientific and technological services: Scientific research and development services; scientific analytical services, namely, chemical and biochemical analysis services for scientific research purposes; scientific analysis of materials and substances; development of scientific analytical methods; pharmaceutical, biopharmaceutical and biotechnological discovery, research and development services; pharmacokinetics research and development services; pre-clinical analytical testing services; laboratory services for analytical testing; bacteria testing and analysis services; sample testing and analysis services; mass spectrometry services; chromatography services; protein and glycoprotein analysis and sequencing; carbohydrate analysis and sequencing; gas phase sequencing; gel electrophoresis analysis; SEC MALLS analysis Size Exclusion Chromatography (SEC) with Multi-Angle Laser-Light Scattering-protein aggregation analysis; amino acid and sugar composition analysis; protein aggregation analysis; scientific research involving structural characterization of biopolymers, small molecule drugs and metabolites; compilation and provision of scientific data in the field of chemistry and biochemistry for research purposes; scientific data interpretation services, namely, scientific analysis in the field of chemistry and biochemistry; preparation and provision of scientific reports, namely, providing scientific information in the fields of chemistry and biochemistry; provision of certificates of analysis, namely, for the purpose of certifying the results of scientific analysis; design of computer software or computer programs for scientific or analytical applications; providing temporary use of on-line, non-downloadable software for automated presentation and interpretation of scientific data; information, advisory and consultancy services relating to all of the aforesaid services
Owner
- Biopharmaspec Limited, JERSEY, GB
- Biopharmaspec Limited, GB
- Biopharmaspec Limited, GB
Prosecution history
- 05 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 05 Jun 2025 — REGISTERED-SEC.71 ACCEPTED
- 02 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Feb 2025 — TEAS SECTION 71 RECEIVED
- 01 Sept 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 23 Feb 2024 — INTERNATIONAL REGISTRATION RENEWED
- 07 Feb 2022 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 07 Feb 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Feb 2022 — POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
- 07 Feb 2022 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 02 Feb 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Jul 2021 — TEAS SECTION 71 & 15 RECEIVED
- 01 Sept 2020 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 03 Aug 2018 — NEW REPRESENTATIVE AT IB RECEIVED
- 13 Feb 2016 — FINAL DECISION TRANSACTION PROCESSED BY IB